Cargando…
Anti-idiotypic Antibodies against BP-IgG Prevent Type XVII Collagen Depletion
Bullous pemphigoid (BP) mainly targets type XVII collagen (COL17). Intravenous immunoglobulin (IVIg) is used to treat numerous autoimmune diseases, including BP. The major mechanism of action for IVIG is thought to be its immunomodulatory effect. However, little is known about the precise mechanisms...
Autores principales: | Kamaguchi, Mayumi, Iwata, Hiroaki, Mori, Yuiko, Toyonaga, Ellen, Ujiie, Hideyuki, Kitagawa, Yoshimasa, Shimizu, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712008/ https://www.ncbi.nlm.nih.gov/pubmed/29230227 http://dx.doi.org/10.3389/fimmu.2017.01669 |
Ejemplares similares
-
Direct Immunofluorescence Using Non-Lesional Buccal Mucosa in Mucous Membrane Pemphigoid
por: Kamaguchi, Mayumi, et al.
Publicado: (2018) -
Immune Reaction to Type XVII Collagen Induces Intramolecular and Intermolecular Epitope Spreading in Experimental Bullous Pemphigoid Models
por: Ujiie, Hideyuki, et al.
Publicado: (2019) -
BP180/Collagen XVII: A Molecular View
por: Tuusa, Jussi, et al.
Publicado: (2021) -
Helper T cells reacting to idiotype on IgG but not IgM
Publicado: (1985) -
Type XVII collagen coordinates proliferation in the interfollicular epidermis
por: Watanabe, Mika, et al.
Publicado: (2017)